Compare GTLB & IRTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GTLB | IRTC |
|---|---|---|
| Founded | 2011 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.9B | 3.7B |
| IPO Year | 2021 | 2016 |
| Metric | GTLB | IRTC |
|---|---|---|
| Price | $22.35 | $121.66 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 27 | 13 |
| Target Price | $37.17 | ★ $197.92 |
| AVG Volume (30 Days) | ★ 5.8M | 381.0K |
| Earning Date | 06-09-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 61.71 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $955,224,000.00 | $747,138,000.00 |
| Revenue This Year | $18.72 | $19.60 |
| Revenue Next Year | $16.05 | $15.94 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | 25.81 | ★ 26.24 |
| 52 Week Low | $18.73 | $103.16 |
| 52 Week High | $52.38 | $210.01 |
| Indicator | GTLB | IRTC |
|---|---|---|
| Relative Strength Index (RSI) | 50.06 | 48.55 |
| Support Level | $20.20 | $119.48 |
| Resistance Level | $24.20 | $124.40 |
| Average True Range (ATR) | 1.23 | 4.54 |
| MACD | 0.38 | 1.02 |
| Stochastic Oscillator | 64.63 | 55.42 |
GitLab Inc operates on an all-remote model. GitLab, a complete DevSecOps platform delivered as a single application. It operates in two competitive landscapes: DevOps point solutions and DevOps platforms. In terms of point solutions that are stitched together, GitLab's offering is substantially different in that it is one platform, one codebase, one interface, and a unified data model that spans the entire DevSecOps lifecycle. DevOps platforms, the principal competitor is Microsoft Corporation following their acquisition of GitHub. GitLab is offered on both self-managed and software-as-a-service (SaaS) models. It is located in the United States, Europe, and Asia Pacific. It focused on accelerating innovation and broadening the distribution of its platform to companies across the world.
iRhythm Holdings Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.